Amgen’s muscle disorder drug has achieved a major late-stage study goal
Amgen said Tuesday that its drug helped improve daily activities, including chewing and swallowing, in patients suffering from a rare disease that causes muscle weakness, meeting the primary goal of a late-stage study.
ПОПУЛЯРНЫЕ ПОСТЫ
IEA warns ‘electricity era’ will come after fossil fuels peak
Октябрь 17, 2024
Easter Island fights global plastic waste vortex
Октябрь 17, 2024
Egypt opens more galleries at its antiquities museum
Октябрь 17, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ